This week's biggest finding comes from an AI experiment showing that a seven-drug combination could keep lung capacity at 98.3% — the closest researchers have ever come to stopping IPF (lung scarring disease) in its tracks using a computer simulation.
FVC = how much air your lungs can push out. Higher % = healthier lungs. A typical IPF patient starts around 50–60%.
This is a computer model result — not a prescription. Always talk to your doctor before changing anything.
Researchers are working hard on IPF (a disease where the lungs slowly fill with scar tissue, making it harder to breathe). This week the database tracking this work grew to over 7,500 studies and nearly 1,900 patient trials worldwide. Most new papers came from Russia and were posted as early-release previews, meaning the science is moving fast even if it hasn't been fully checked yet.
An AI tested hundreds of drug combinations and found one seven-drug mix that kept lung capacity (FVC — a measure of how much air your lungs can hold) at an impressive 98.3%. For comparison, healthy lungs score 100%. That means this combination nearly stopped the scarring completely in the computer model. The drugs target several different pathways that cause scarring, which is why using many together seems so powerful. Real human trials still need to happen.
One question to ask your lung doctor at your next visit: 'Are there any combination drug trials I might qualify for, now that researchers are testing several treatments at once?'